The laboratory services company is scheduled to report second-quarter earnings on Aug. 1. On average, analysts expect earnings of 49 cents a share on revenue of $539.5 million."PKI's genomics strategy centers on offering unique services for the front and back ends of the NGS workflow," Bank of America Merrill Lynch analysts wrote in a May 15 report. "At the front end, the recent Caliper acquisition provides automated liquid handling and NGS sample preparation solutions, and while this market has become more competitive, PKI noted that pricing remains healthy. Beyond NGS, Caliper also adds new in vivo imaging technologies that complement PKI's pharma portfolio. On the back end, PKI believes that its emerging informatics business will gain traction over time as it aids with data access, storage, transfer and analysis, with a goal of facilitating the transition of NGS into the clinic. Management believes that this is roughly a $500 market opportunity, and expects to launch new data analysis products later this year." Forward Annual Dividend Yield: 1.1% -- Written by Alexandra Zendrian
>To contact the writer of this article, click here: Alexandra Zendrian >To submit a news tip, send an email to: firstname.lastname@example.org. >To follow the writer on Twitter, go to Alexandra Zendrian.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV